National Natural Science Foundation of China(82170413,82170342,82200377);Guangdong Basic and Applied Basic Research Foundation(2021A1515012546,2022A1515012474);Shanghai Yangfan Project(21YF1440000);Innovation Team of General Universities in Guangdong Province(2023KCXTD025);Guangzhou Science and Technology Plan(202102010101,202201020220);Student Innovation Program of Guangzhou Medical University(to S.J.L.).
The commercially available drug-eluting stent with limus (rapamycin, everolimus, etc.) or paclitaxel inhibits smooth muscle cell (SMC), reducing the in-stent restenosis, whereas damages endothelial cell (EC) and delay...